Brian Sullivan

Brian Sullivan

Signal active

Co-Founder, Chairman, CEO

Bio

Brian Sullivan has served as a director of the Company since the Merger in 2005. He served as a director of Entegris Minnesota and as a member of its Compensation and Stock Option Committee from December 2003 until the Merger with the Company; and served as a member of the Management Development and Compensation Committee of the Company from the Merger until May 2008 at which time he joined the Audit and Finance Committee.

Brian Sullivan is currently Chairman and CEO of Celcuity LLC, a biotechnology company he co-founded in 2012. Brian Sullivan was Chairman and CEO of SterilMed, Inc from 2002 until he retired from that company in 2011 in conjunction with its sale to Johnson & Johnson.Brian Sullivan co-founded Recovery Engineering, Inc. in 1986, and was Chairman and Chief Executive Officer until it was sold in 1999 to Proctor & Gamble Co. Brian Sullivan served as a member of the board of directors of Virtual Radiologic Corporation from 2008 until that company was sold in 2010, and serves as a director of several private companies and non-profit organizations. Brian Sullivan holds an A.B. degree from Harvard University.

Location

Minneapolis, Minnesota, United States, North America

Social

Primary Organization

Celcuity

Celcuity

Founded

2012

Employees

11-50

Industry

Biotechnology, Health Care, Therapeutics, Health Diagnostics

Jobs history

0

N/A

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Brian Sullivan is the Co-Founder, Chairman, CEO at Celcuity, based in United States, North America. With a background in Biotechnology, Brian Sullivan has a rich history of leadership and innovation. Brian Sullivan studied A.B unknown @ Harvard University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

Brian Sullivan has made 1 investments. Their Latest investment was Post-IPO Equity - Celcuity on May 16, 2022

Number of investment

1

Number of exits

1

Personal investment

1

Annouced DateOrganization NameFunding RoundMoney Raised
May 16, 2022
Celcuity Celcuity
Post-IPO Equity - Celcuity
100.0M

Partner investment

0

There is no partner investment available on this profile

Exits

1

exit.name Celcuity

Celcuity

Celcuity is a clinical-stage biotechnology company translating discoveries of new cancer sub-types into pioneering compa...

Invest in industries

Recent Activity

There is no recent news or activity for this profile.